N-3 fatty acid supplementation mediates lipid profile, including small dense LDL, when combined with statins: a randomized double blind placebo controlled trial

Table 2 Comparison of diets during the intervention periods as assessed by dietary records

Dietary Compounds	Placebo	n-3 FA	P
Dietary Compounds	Median (Q₁, Q₃)	Median (Q₁, Q₃)	P
Total energy (kcal)	3222 (3090, 3420)	3274 (3105, 3420)	0.879
Total energy (MJ)	13.5 (12.9, 14.3)	13.7 (13.0, 14.3)
CHO (%E)	51.25 (50.8, 52)	51.25 (50.9, 52)	0.629
*Free Sugars (%E)*	5.25 (5.1, 6.1)	5.25 (5.2, 5.3)	0.820
*Fiber (g)*	18.3 (17.6, 19.4)	17.9 (16.4, 18.8)	0.693
Protein (%E)	16.4 (16.3, 17.2)	16.4 (15.9, 17.1)	0.378
Fat (%E)	32.1 (31.4, 32.9)	32.1 (30.7, 32.7)	0.859
*SFA (%E)*	9.5 (8.9, 9.9)	9.5 (8.9, 9.8)	0.962
*MUFA (%E)*	10.9 (10.6, 11.3)	11.2 (10.6, 11.9)	0.364
*PUFA (%E)*	9.25 (8.8, 9.6)	9.25 (8.8, 10.8)	0.972
*EPA (%E)*	0.91 (0.89, 0.98)	0.91 (0.89, 0.97)	0.730
*DHA (%E)*	0.92 (0.91, 0.97)	0.92 (0.91, 0.97)	0.392

Values are median (Q₁, Q₃), Q₁: First quartile and Q₃: Third quartile. Values were derived from food composition tables

ISSN: 1476-511X